Up to 15pc hike in prices of medicines, 9pc for life-saving drugs approved

Published January 11, 2019
The drug manufacturing companies had been demanding 40pc increase in medicines' prices. — AFP/File
The drug manufacturing companies had been demanding 40pc increase in medicines' prices. — AFP/File

The Drug Regulatory Authority of Pakistan (Drap) on Friday, with the approval of the federal government, announced up to 15 per cent hike in the prices of medicines, apart from life-saving drugs.

Notification for increase in price of medicines.
Notification for increase in price of medicines.

According to a notification by Drap, available with DawnNewsTV, nine per cent hike has been approved in the prices of life-saving drugs, whereas a 15pc hike was approved in the prices of all other medicines.

"The revised maximum retail prices shall be printed on the label in the manner prescribed by the Drugs [Labelling and Packaging] Rules, 1986 and the manufacturers and importers of drugs shall furnish calculations of revised maximum retail price of drugs to the Division of Costing and Pricing of the Drug Regulatory Authority of Pakistan before affecting the increase," adds the notification.

The Pakistan Pharmaceutical Manufacturers Association (PPMA) Chairperson Zahid Saeed said that the drug manufacturing companies have been demanding 40pc increase in the prices of medicines.

He said that the increase was inevitable because of the increase in dollar's value, adding that PPMA was reviewing the contents of the notification.

Last year, a three-judge Supreme Court bench had taken up a suo motu notice about the increase in prices of drugs. In August, Chief Justice of Pakistan Mian Saqib Nisar had directed Drap to decide within 10 weeks all pending cases of pharmaceutical companies regarding medicine prices.

He had said the existing prices of all medicines would remain frozen till a decision on the cases. While rejecting a petition moved by one of the drug importers challenging the Drap policy, he observed that the court had no jurisdiction to interfere in policy matters of the government.

Follow Dawn Business on Twitter, LinkedIn, Instagram and Facebook for insights on business, finance and tech from Pakistan and across the world.

Opinion

Editorial

NAP revival
Updated 17 Mar, 2025

NAP revival

This bloody cycle of violence will continue unless action is complemented with social, economic, political efforts in Balochistan and KP.
New reality
17 Mar, 2025

New reality

THE US retreat from global climate finance commitments could not have come at a worse time. Pakistan faces an...
Killer traffic
17 Mar, 2025

Killer traffic

MYSTERIOUS and unstoppable. It is these words that perhaps best describe the recent surge in traffic-related...
After the review
Updated 16 Mar, 2025

After the review

Should prepare economy for durable growth by attracting foreign private investments to boost productivity and exports.
Embracing crypto
16 Mar, 2025

Embracing crypto

IT seems a little prod was all it took for Pakistan to finally ‘embrace the future’. The Pakistan Crypto Council...
Fault lines
16 Mar, 2025

Fault lines

IT was a distressing spectacle, though a sadly predictable one. As the National Assembly took up for discussion the...